ShareValue scores for INCR: Valuation 56, Quality 52, Growth 36, Health 47.
INCRNASDAQ
InterCure Ltd.
$0.93
(-2.77%)
INCRNASDAQ
InterCure Ltd.
$0.93(-2.77%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
56
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
36
Weak
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
43
Neutral
Price Trend
Company Details
About
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Market Cap$53M
P/E RatioN/A
Dividend YieldNone
Sector Rank#2002
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026